Fattaey out, Dentzer up at Curis; Belgian investors back Spanish orphan drug biotech; Verastem scores China deal
→ Spain’s Minoryx Therapeutics has raised €21.3 million ($24.9 million) to explore new uses of its lead drug, thanks to …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
